Carl Zeiss Meditec Ag (CZMWF) Q2 2024 Earnings Call

Investor webinar replay

Watch the replay and follow the connected company analysis, news, and investor updates for Carl Zeiss Meditec Ag.

Watch the replay

Replay transcript excerpt

WEBVTT 00:00:00.031 -- 00:00:05.356 Ladies and gentlemen, to our analyst conference on the first quarter of 2024 at 00:00:05.356 -- 00:00:07.356 Bechtle 00:00:07.478 -- 00:00:09.440 AG. 00:00:09.440 -- 00:00:14.162 I am delighted to see that our event is met with such interest. 00:00:14.865 -- 00:00:19.949 Before I follow my brief introduction by presenting the key figures for our 00:00:19.949 -- 00:00:24.253 business performance in the first quarter of the current year 2024, 00:00:24.253 -- 00:00:28.938 I would like to make what I consider to be the most important statement at this point 00:00:28.938 -- 00:00:30.457 already. 00:00:30.457 -- 00:00:33.481 It is two in particular. 00:00:33.481 -- 00:00:39.308 One, against the backdrop of the persistently challenging macroeconomic 00:00:39.308 -- 00:00:45.155 conditions, our performance in Q1 can be considered very solid. 00:00:45.155 -- 00:00:50.441 This is particularly true when measured against the figures of many of our peers 00:00:50.441 -- 00:00:52.208 or competitors. 00:00:52.208 -- 00:00:54.568 Two, nevertheless, 00:00:54.650 -- 00:00:59.675 from today's perspective, the first three months of the current financial year 00:00:59.675 -- 00:01:03.558 are not really a reliable indicator for the rest of the year. 00:01:03.558 -- 00:01:05.698 And moreover, 00:01:06.041 -- 00:01:11.125 we continue to assume that IT demand will improve in the 00:01:11.125 -- 00:01:16.210 second half of the year. And this is why we are sticking to our ambitious targets for 00:01:16.210 -- 00:01:21.274 the year as a whole. So much, ladies and gentlemen, for my preliminary 00:01:21.274 -- 00:01:26.246 remarks. which may serve as something like a heading for our first quarter of the current 00:01:26.246 -- 00:01:31.635 financial year. As us...